To improve the quality of special research, on November 25, 2021, the QA department of the Drug Safety Evaluation Research Center of Shandong Xinbo Pharmaceutical Research Co., Ltd. organized a special quality improvement seminar. The company's general manager Shen Lianzhong, QA director Tang Hengke, department heads and project leaders (SD), and main technical leaders attended the meeting.

The meeting summarized and analyzed the problems found during the annual inspection of the QA department, and discussed corresponding improvement measures.